These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18229399)

  • 21. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men.
    Grundtvig M; Hagen TP; German M; Reikvam A
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):174-9. PubMed ID: 19247184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for prediction of cardiovascular events.
    Hauswald M
    N Engl J Med; 2007 Apr; 356(14):1474; author reply 1474-5. PubMed ID: 17415900
    [No Abstract]   [Full Text] [Related]  

  • 23. Women's hearts need extra attention. Diagnosis and treatment of heart disease in women still lags behind that in men.
    Harv Heart Lett; 2009 Apr; 19(8):3. PubMed ID: 19681199
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis case definition: time for critical re-assessment?
    Marais B; Schaaf S; Hesseling A; Gie R; Breen R; Lipman M
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1217; author reply 1218. PubMed ID: 18812054
    [No Abstract]   [Full Text] [Related]  

  • 25. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial infarction in women: promoting symptom recognition, early diagnosis, and risk assessment.
    Zbierajewski-Eischeid SJ; Loeb SJ
    Dimens Crit Care Nurs; 2009; 28(1):1-6; quiz 7-8. PubMed ID: 19104242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
    Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
    Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women and heart disease: an update.
    Quinn JR
    Nurs Manage; 2008 Aug; 39(8):22-7; quiz 27-8. PubMed ID: 18690147
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.
    Romero-Corral A; Sierra-Johnson J; Lopez-Jimenez F; Thomas RJ; Singh P; Hoffmann M; Okcay A; Korinek J; Wolk R; Somers VK
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):418-25. PubMed ID: 18431365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telltale test for the heart. A key protein tracks inflamed arteries.
    Comarow A
    US News World Rep; 2000 Apr; 128(13):52. PubMed ID: 10788255
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk stratification and prognostic factors in the post-myocardial infarction patient.
    Cannon CP; Greenberg BH
    Am J Cardiol; 2008 Sep; 102(5A):13G-20G. PubMed ID: 18722187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein variations for different chronic somatic disorders.
    Lund Håheim L; Nafstad P; Olsen I; Schwarze P; Rønningen KS
    Scand J Public Health; 2009 Aug; 37(6):640-6. PubMed ID: 19372230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients.
    Padayachee L; Rodseth RN; Biccard BM
    Anaesthesia; 2009 Apr; 64(4):416-24. PubMed ID: 19317708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
    Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.